文献速递性腺与生殖内分泌糖尿病肥胖与代谢综合征

原发性严重胰岛素抵抗中的卵巢高雄激素血症及对促性腺激素释放激素类似物的反应

Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

本研究回顾性分析了2个严重胰岛素抵抗(SIR)国家转诊中心的女性患者,涵盖脂肪营养不良、原发性胰岛素信号障碍及特发性SIR三类亚型。结果显示SIR可导致严重高雄激素血症及PCOS样卵巢改变;GnRH类似物治疗在全部6例可评估患者中改善了高雄激素症状并降低血清总睾酮,且不受SIR病因影响。

要点

  • 严重胰岛素抵抗患者可出现严重高雄激素血症和PCOS样卵巢病理。
  • 胰岛素信号障碍亚组总睾酮升高与SHBG升高相关,脂肪营养不良组胰岛素与SHBG呈负相关。
  • GnRH类似物在多种SIR亚型中可改善高雄激素症状并降低总睾酮。

核心结论

  • SIR无论源于近端胰岛素信号缺陷还是脂肪发育异常,均可导致严重高雄激素血症和PCOS样卵巢改变。
  • 胰岛素抵抗与游离睾酮的关系在两组间不同,由SHBG介导。
  • GnRH类似物在多种SIR亚表型中均有益。

研究设计与样本

  • 回顾性病历审查,来自2个SIR国家转诊中心。
  • 纳入有血清总睾酮记录的女性SIR患者,包括185例脂肪营养不良、65例原发性胰岛素信号障碍和29例特发性SIR。

主要发现

  • 血清总睾酮范围从检测不到至1562 ng/dL(54.2 nmol/L;中位数40.3 ng/dL [1.40 nmol/L];n=279)。
  • 游离睾酮范围从检测不到至18.0 ng/dL(0.625 nmol/L;中位数0.705 ng/dL [0.0244 nmol/L];n=233)。
  • 胰岛素信号障碍亚组总睾酮较高但游离睾酮不高,归因于血清SHBG浓度较高。
  • 胰岛素信号障碍亚组胰岛素与SHBG正相关,脂肪营养不良组则呈负相关。
  • 9例有卵巢组织者中8例组织学符合PCOS;6例接受GnRH类似物治疗者全部在促性腺激素抑制后高雄激素症状改善且血清总睾酮降低。

关键数值与推荐

  • 血清总睾酮中位数40.3 ng/dL(1.40 nmol/L),范围检测不到至1562 ng/dL(54.2 nmol/L),n=279。
  • 血清游离睾酮中位数0.705 ng/dL(0.0244 nmol/L),范围检测不到至18.0 ng/dL(0.625 nmol/L),n=233。
  • 9例有卵巢组织患者中8例组织学符合PCOS。
  • 6例接受GnRH类似物治疗者全部显示高雄激素症状改善及血清总睾酮降低。

临床怎么用

  • 对SIR女性应评估高雄激素血症,包括总睾酮和游离睾酮及SHBG。
  • GnRH类似物可用于SIR相关高雄激素症状的治疗,需结合病因亚型个体化评估。

局限性

  • 回顾性病历审查设计。
  • 卵巢组织病理和GnRH类似物治疗评估的样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Insulin resistance (IR) is associated with polycystic ovaries and hyperandrogenism, but underpinning mechanisms are poorly understood and therapeutic options are limited. OBJECTIVE: To characterize hyperandrogenemia and ovarian pathology in primary severe IR (SIR), using IR of defined molecular etiology to interrogate disease mechanism. To extend evaluation of gonadotropin-releasing hormone (GnRH) analogue therapy in SIR. METHODS: Retrospective case note review in 2 SIR national referral centers. Female patients with SIR with documented serum total testosterone (TT) concentration. RESULTS: Among 185 patients with lipodystrophy, 65 with primary insulin signaling disorders, and 29 with idiopathic SIR, serum TT ranged from undetectable to 1562 ng/dL (54.2 nmol/L; median 40.3 ng/dL [1.40 nmol/L]; n = 279) and free testosterone (FT) from undetectable to 18.0 ng/dL (0.625 nmol/L; median 0.705 ng/dL [0.0244 nmol/L]; n = 233). Higher TT but not FT in the insulin signaling subgroup was attributable to higher serum sex hormone-binding globulin (SHBG) concentration. Insulin correlated positively with SHBG in the insulin signaling subgroup, but negatively in lipodystrophy. In 8/9 patients with available ovarian tissue, histology was consistent with polycystic ovary syndrome (PCOS). In 6/6 patients treated with GnRH analogue therapy, gonadotropin suppression improved hyperandrogenic symptoms and reduced serum TT irrespective of SIR etiology. CONCLUSION: SIR causes severe hyperandrogenemia and PCOS-like ovarian changes whether due to proximal insulin signaling or adipose development defects. A distinct relationship between IR and FT between the groups is mediated by SHBG. GnRH analogues are beneficial in a range of SIR subphenotypes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Huang-Doran I, Kinzer AB, Jimenez-Linan M, et al. Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance. J Clin Endocrinol Metab. 2021. PMID: 33901270. doi:10.1210/clinem/dgab275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。